MDxHealth SA SEC filings MDXH
MDxHealth SA has 183 filings in SEC EDGAR's recent list, going back to Aug 9, 2021. Its latest annual report, Form 20-F, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 30, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Apr 3, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 25, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Apr 25, 2022 | Dec 31, 2021 |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- MDXH (Nasdaq)
- Incorporated in
- Belgium
- Headquarters
- Herstal, Belgium
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1872529
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.